Literature DB >> 7044059

Clinical aspects of gastrointestinal mucus.

G Forstner, A Wesley, J Forstner.   

Abstract

In such a bird's eye view of a very complicated and complex literature it is inevitable that significant contributions, particularly from earlier investigators, will have been overlooked. We have tried, however, to provide a reasonable framework for the many presentations and discussions which will take place at this conference. As in the past, it is evident that much needs to be done to reconcile the excellent histochemical studies of gastrointestinal mucus in many diseases with the increasing knowledge of mucin structure and composition. This will only be achieved by extraction of highly pure mucin from diseased bowel. In this regard, post mortem material provides an opportunity for mucin researchers which is not available to workers in other fields because of relative freedom from decomposition. The wedding of mucin technology with immunology is also a major priority. Immunoassay techniques provide the answer to quick and accurate product identification in secretion studies. Specific monoclonal antibodies will provide the route to structural differentiation of antigens in complex mixtures. It is also evident that we must seek to develop a variety of controllable models for the study of functional parameters of mucus in physiological conditions, parasite rejection, neoplasia and inflammatory states. Promising initiatives have been touched upon in this review, but these must only be the beginning. One must conclude, however, by recognizing that advances in knowledge have been truly remarkable since the last conference in 1976. One senses that some of the keys which will one day unlock the gates of this "ill-defined" kingdom are already in hand, while the remainder are at least within reach.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044059     DOI: 10.1007/978-1-4615-9254-9_32

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

1.  Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

2.  Human colonic goblet cells. Demonstration of distinct subpopulations defined by mucin-specific monoclonal antibodies.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Effect of guinea pig or monkey colonic mucus on Shigella aggregation and invasion of HeLa cells by Shigella flexneri 1b and 2a.

Authors:  G Dinari; T L Hale; O Washington; S B Formal
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Cholera enterotoxin-induced mucus secretion and increase in the mucus blanket of the rabbit ileum in vivo.

Authors:  G J Leitch
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

5.  Development of a monoclonal antibody specifically reactive to gastrointestinal goblet cells.

Authors:  M Vecchi; S Sakamaki; B Diamond; A B Novikoff; P M Novikoff; K M Das
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Biosynthesis of mucin type O-glycans: lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression.

Authors:  I Brockhausen; F Vavasseur; X Yang
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

8.  Biosynthesis and secretion of human colonic mucin glycoproteins.

Authors:  A C Smith; D K Podolsky
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.

Authors:  H Morita; M G Kettlewell; D P Jewell; P W Kent
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

10.  A membrane-associated neuraminidase in Entamoeba histolytica trophozoites.

Authors:  I A Udezulu; G J Leitch
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.